Related Experiment Videos
Stem-cell therapy for hepatobiliary pancreatic disease
Takahisa Fujikawa1, Seh-Hoon Oh, Tom Shupe
1Department of Pathology, Immunology and Laboratory Medicine and Program in Stem Cell Biology and Regenerative Medicine, College of Medicine, University of Florida, Gainesville, FL, USA.
Journal of Hepato-Biliary-Pancreatic Surgery
|July 5, 2005
Summary
Stem cells offer a promising alternative source for pancreatic beta cells and hepatocytes, crucial for treating type I diabetes and liver diseases. Further research is needed to overcome challenges in translating stem cell biology into clinical therapies.
Area of Science:
- Regenerative Medicine
- Stem Cell Biology
- Hepatology
- Endocrinology
Background:
- Pancreatic beta cells and hepatocytes are vital for treating type I diabetes and liver diseases.
- Current cell transplantation therapies are limited by insufficient graft cell availability.
- Existing treatments for acute hepatic failure using fetal and adult hepatocytes have seen limited clinical success.
Purpose of the Study:
- To review the current understanding and controversies surrounding embryonic and adult stem cells for hepatobiliary and pancreatic diseases.
- To provide a framework for addressing the challenges in translating stem cell biology into clinical applications.
- To explore alternative cell sources for transplantation therapies.
Main Methods:
- Literature review of scientific understanding and controversies in stem cell biology.
- Analysis of current strategies for producing mature beta cells and hepatocytes.
- Discussion of challenges in clinical translation of stem cell therapies.
Main Results:
- Significant progress has been made in developing strategies to produce mature beta cells and hepatocytes.
- Embryonic and adult stem cells show potential for treating hepatobiliary and pancreatic diseases.
- Key challenges remain in the clinical application of stem cell-derived cells.
Conclusions:
- Stem cell-derived beta cells and hepatocytes represent a potential solution to the limited availability of cells for transplantation.
- Overcoming scientific and technical hurdles is essential for successful clinical translation.
- Continued research into stem cell properties and differentiation is critical for advancing therapies for diabetes and liver disease.